The Role of Long Term Label-Retaining Cells in the Treatment of Erectile Dysfunction by Vacuum Erectile Device
Authors:
Open Access
- 11 October 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 9 (6) , 100442
Abstract
Introduction: Vacuum erectile device (VED) therapy is commonly used for penile rehabilitation after radical prostatectomy, however, the underlying mechanism of this effect is not fully understood. Aim: To evaluate the presence of label-retaining cells (LRCs), cells with long-term retention of 5-ethynyl-2-deoxyuridine (EdU) labeling and recognized as adult stem cells or progenitor-like cells, in cavernous tissue after VED treatment using a BCNC rat model. Methods: Postnatal pups (1 day old) of Sprague Dawley (SD) rats were intraperitoneally injected with EdU (50 ug/g, BID for 3 days) and BCNC surgery was conducted at 6 weeks old (designated as natal-labeled rats). Adult SD rats underwent BCNC surgery and EdU injection (50 ug/g, once) after surgery (designated as adult-labeled rats). One week after surgery, both natal- and adult-labeled rats received daily VED treatment for 4 weeks. Intracavernous pressure (ICP) and mean arterial pressure (MAP) were measured for all rats and then the penile tissue was harvested. The ratio of ICP/MAP was calculated to represent erectile function. Penile tissue was examined by immunofluorescence staining to detect EdU positive cells. Main Outcome Measures: The ratio of Intracavernous pressure (ICP) /MAP and the percentage of EdU positive cells were measured. Results: The erectile function was impaired after BCNC and partially restored after VED treatment in both natal- and adult-labeled rats (P < .05). There was no difference in the percentage of EdU positive cells in natal-labeled rat cavernous tissue in BCNC group compared with VED group. Among the adult-labeled rats, the percentage of EdU positive cells increased in BCNC group (P < .05) but didn't change significantly after VED treatment (P = .35). Conclusion: LRCs may play a limited role in the restoration of erectile dysfunction through VED treatment after BCNC.Keywords
Funding Information
- Department of Surgery, UTHSC-Houston.
This publication has 24 references indexed in Scilit:
- Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidenceAsian Journal of Andrology, 2013
- Both Immediate and Delayed Intracavernous Injection of Autologous Adipose-derived Stromal Vascular Fraction Enhances Recovery of Erectile Function in a Rat Model of Cavernous Nerve InjuryEuropean Urology, 2012
- Evaluation of 5-ethynyl-2′-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous systemBrain Research, 2010
- Cell type specific applicability of 5‐ethynyl‐2′‐deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometryCytometry Part A, 2009
- 5-Year Urinary and Sexual Outcomes After Radical Prostatectomy: Results From the Prostate Cancer Outcomes StudyJournal of Urology, 2008
- A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomyBJU International, 2007
- Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cellsNature Cell Biology, 2006
- Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile functionInternational Journal Of Impotence Research, 2005
- Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strandsDevelopment, 2005
- Slowly cycling (label‐retaining) epidermal cells behave like clonogenic stem cells in vitroCell Proliferation, 1994